CXCL8 and Cognitive impairment: Clinical studies also support the role of IL-8 in AD [38], with elevated IL-8 concentrations observed in the cerebrospinal fluid of AD patients and individuals with mild cognitive impairment [39], suggesting its relevance in the early phases of the disease.